These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 15472839)

  • 1. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
    Dagan R; Givon-Lavi N; Zamir O; Sikuler-Cohen M; Guy L; Janco J; Yagupsky P; Fraser D
    J Infect Dis; 2002 Apr; 185(7):927-36. PubMed ID: 11920317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.
    Cohen R; Levy C; Bingen E; Koskas M; Nave I; Varon E
    Pediatr Infect Dis J; 2012 Mar; 31(3):297-301. PubMed ID: 22330166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
    Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
    Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.
    Bogaert D; Veenhoven RH; Ramdin R; Luijendijk IH; Rijkers GT; Sanders EA; de Groot R; Hermans PW
    Vaccine; 2005 Apr; 23(20):2607-13. PubMed ID: 15780443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada.
    Kellner JD; Scheifele D; Vanderkooi OG; Macdonald J; Church DL; Tyrrell GJ
    Pediatr Infect Dis J; 2008 Jun; 27(6):526-32. PubMed ID: 18458650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers.
    Dagan R; Givon-Lavi N; Zamir O; Fraser D
    Pediatr Infect Dis J; 2003 Jun; 22(6):532-40. PubMed ID: 12799510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
    Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
    Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life.
    Ghaffar F; Barton T; Lozano J; Muniz LS; Hicks P; Gan V; Ahmad N; McCracken GH
    Clin Infect Dis; 2004 Oct; 39(7):930-8. PubMed ID: 15472842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.
    Revai K; McCormick DP; Patel J; Grady JJ; Saeed K; Chonmaitree T
    Pediatrics; 2006 May; 117(5):1823-9. PubMed ID: 16651345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.
    Moore MR; Hyde TB; Hennessy TW; Parks DJ; Reasonover AL; Harker-Jones M; Gove J; Bruden DL; Rudolph K; Parkinson A; Butler JC; Schuchat A
    J Infect Dis; 2004 Dec; 190(11):2031-8. PubMed ID: 15529269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population.
    Millar EV; O'Brien KL; Watt JP; Bronsdon MA; Dallas J; Whitney CG; Reid R; Santosham M
    Clin Infect Dis; 2006 Jul; 43(1):8-15. PubMed ID: 16758412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
    Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
    Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
    Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
    J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.
    Shea KM; Weycker D; Stevenson AE; Strutton DR; Pelton SI
    Vaccine; 2011 Oct; 29(45):8042-8. PubMed ID: 21871518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial.
    van Gils EJ; Veenhoven RH; Rodenburg GD; Hak E; Sanders EA
    Vaccine; 2011 Oct; 29(44):7595-8. PubMed ID: 21893151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.